Boreice Biotech completed over 100 million RMB in Series A financing.

36Kr learned that "BioRizer Biotech" announced the completion of over RMB 100 million in Series A financing. This round of financing was led by CJ Capital and followed by Doton Investment. Harvest Capital served as the exclusive financial advisor for this round of financing. As of this round, BioRizer Biotech has completed a cumulative financing of over RMB 300 million. The funds from this round will be mainly used to expand the global layout, accelerate the expansion of the GMP-compliant biosecurity testing platform, and continuously improve the high-quality biosecurity industry layout.